BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35200564)

  • 1. Comprehensive Laboratory Diagnostic Workup for Patients with Suspected Intraocular Lymphoma including Flow Cytometry, Molecular Genetics and Cytopathology.
    Shumilov E; Mazzeo P; Zinkernagel MS; Legros M; Porret N; Romagna L; Haase D; Lenz G; Novak U; Banz Y; Pabst T; Bacher U
    Curr Oncol; 2022 Jan; 29(2):766-776. PubMed ID: 35200564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction.
    Hiemcke-Jiwa LS; Ten Dam-van Loon NH; Leguit RJ; Nierkens S; Ossewaarde-van Norel J; de Boer JH; Roholl FF; de Weger RA; Huibers MMH; de Groot-Mijnes JDF; Kuiper JJW
    JAMA Ophthalmol; 2018 Oct; 136(10):1098-1104. PubMed ID: 30027272
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Narasimhan S; Joshi M; Parameswaran S; Rishi P; Khetan V; Ganesan S; Biswas J; Sundaram N; Sreenivasan J; Verma S; Krishnamurthy V; Subramanian K
    Indian J Ophthalmol; 2020 Oct; 68(10):2160-2165. PubMed ID: 32971631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Relevance of the High Prevalence of MYD88 L265P Mutated Vitreoretinal Lymphoma Identified by Droplet Digital Polymerase Chain Reaction.
    Shi H; Zhou X; Chen B; Xiao J; Li Y; Zhou X; Zhou Q; Chen K; Wang Q
    Ocul Immunol Inflamm; 2021 Apr; 29(3):448-455. PubMed ID: 31603365
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of clonal immunoglobulin heavy chain rearrangements in ocular lymphoma.
    Baehring JM; Androudi S; Longtine JJ; Betensky RA; Sklar J; Foster CS; Hochberg FH
    Cancer; 2005 Aug; 104(3):591-7. PubMed ID: 15973665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYD88 L265P MUTATION DETECTION IN THE AQUEOUS HUMOR OF PATIENTS WITH VITREORETINAL LYMPHOMA.
    Miserocchi E; Ferreri AJM; Giuffrè C; Cangi MG; Francaviglia I; Calimeri T; Ponzoni M; Pecciarini L; Bandello FM; Modorati GM
    Retina; 2019 Apr; 39(4):679-684. PubMed ID: 30204732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular profiling of vitreous fluid by massively parallel sequencing: a case series.
    Hirschhorn JW; Snider JS; Lindsey KG; Schandl CA
    J Am Soc Cytopathol; 2020; 9(4):254-257. PubMed ID: 32423686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometry immunophenotyping of vitreous specimens does not contribute to diagnosis of lymphoma without supporting morphologic features.
    Cantu CA; Green CL; Cummings TJ; Liu B; Dash RC
    Diagn Cytopathol; 2019 Apr; 47(4):275-281. PubMed ID: 30485724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidisciplinary Diagnostic Approach in Intraocular Lymphoma Featuring Pseudo-hypopyon: Case Series and Literature Review.
    Zhou HP; Tanaka R; Kaburaki T
    Ocul Immunol Inflamm; 2021 Apr; 29(3):490-495. PubMed ID: 32965144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the reactive T-cell infiltrate in uveitis and intraocular lymphoma with flow cytometry of vitreous fluid (an American Ophthalmological Society thesis).
    Davis JL; Ruiz P; Shah M; Mandelcorn ED
    Trans Am Ophthalmol Soc; 2012 Dec; 110():117-29. PubMed ID: 23818738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
    Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center.
    Giuffrè C; Cicinelli MV; Marchese A; Modorati GM; Brambati M; Ferreri AJM; Calimeri T; Ponzoni M; Bandello F; Miserocchi E
    Ocul Immunol Inflamm; 2021 Apr; 29(3):472-478. PubMed ID: 32845738
    [No Abstract]   [Full Text] [Related]  

  • 13. Vitreoretinal Lymphoma: Optimizing Diagnostic Yield and Accuracy.
    Santos MC; Jiang A; Li AS; Rao PK; Wilson B; Harocopos GJ
    Am J Ophthalmol; 2022 Apr; 236():120-129. PubMed ID: 34626574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective cytological study of intraocular lymphoma using vitreous and intraocular perfusion fluid.
    Kinoshita Y; Takasu K; Adachi Y; Yuri T; Nagumo S; Shikata N
    Diagn Cytopathol; 2012 Jul; 40(7):604-7. PubMed ID: 22707324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic yield of vitrectomy in eyes with suspected posterior segment infection or malignancy.
    Mruthyunjaya P; Jumper JM; McCallum R; Patel DJ; Cox TA; Jaffe GJ
    Ophthalmology; 2002 Jun; 109(6):1123-9. PubMed ID: 12045054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of intraocular lesions using vitreous humor and intraocular perfusion fluid cytology: Experience with 83 Cases.
    Kinoshita Y; Takasu K; Kobayashi TK; Yuri T; Tsubura A; Shikata N
    Diagn Cytopathol; 2015 May; 43(5):353-9. PubMed ID: 25334001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of intraocular lymphoma by flow cytometry.
    Davis JL; Viciana AL; Ruiz P
    Am J Ophthalmol; 1997 Sep; 124(3):362-72. PubMed ID: 9439362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 25-gauge transconjunctival diagnostic vitrectomy in suspected cases of intraocular lymphoma: a case series and review of the literature.
    Kanavi MR; Soheilian M; Hosseini SB; Azari AA
    Int J Ophthalmol; 2014; 7(3):577-81. PubMed ID: 24967211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 25-Gauge transconjunctival sutureless vitrectomy for the diagnosis of intraocular lymphoma.
    Yeh S; Weichel ED; Faia LJ; Albini TA; Wroblewski KK; Stetler-Stevenson M; Ruiz P; Sen HN; Chan CC; Nussenblatt RB
    Br J Ophthalmol; 2010 May; 94(5):633-8. PubMed ID: 20447965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraocular Lymphoma: Descriptive Data of 26 Patients Including Clinico-pathologic Features, Vitreous Findings, and Treatment Outcomes.
    Abu Samra K; Oray M; Ebrahimiadib N; Lee S; Anesi S; Foster CS
    Ocul Immunol Inflamm; 2018; 26(3):347-352. PubMed ID: 27438792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.